NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine - https://archive.org/web/.

Categories: Associated Press

11/1/2018

Thoughtful and thorough, AP story looks at growing trend of using ketamine for depression

10/8/2018

AP offers strong reporting about the evidence for a drug treatment for moderate bone loss

8/16/2018

Multigene test may find risk for common diseases, but there’s no evidence it will make anyone healthier

4/11/2018

Diagnosing Alzheimer’s using biomarkers–AP makes it clear that there is no benefit to patients

3/29/2018

AP story on ‘selfie medicine’ adherence programs overlooked evidence showing they don’t work well

3/1/2018

AP’s widely-reported story on IV fluids oversimplified the research

1/18/2018

‘It’s unknown whether treatment increases survival,’ AP wisely notes about new breast cancer drug

1 11/28/2017

Patient anecdote outweighs data in AP’s look at lymph node transfer surgery

5 10/25/2017

Brief but informative report from AP on newly approved shingles vaccine

10/10/2017

AP makes it clear that gene therapy has uncertain future for treating ALD

Story Reviews

Systematic, Criteria-Driven

@HealthNewsRevu

HealthNewsRevuHealthNewsReview.org@HealthNewsRevu·

Our 3,222 reviews of health care journalism & PR will be gone soon. The rest of the website will remain. Read details. https://www.healthnewsreview.org/2021/01/our-3222-systematic-reviews-of-journalism-pr-will-be-gone-soon/

Reply on Twitter 1351160348615782403Retweet on Twitter 13511603486157824032Like on Twitter 13511603486157824032Twitter 1351160348615782403
HealthNewsRevuHealthNewsReview.org@HealthNewsRevu·

Year-ender: links to all 44 articles I published in 2020 - a year of too-frequent distortion, deceit and misinformation, worst I’ve seen in my 47-year career. https://www.healthnewsreview.org/2020/12/reflections-on-2020-you-cant-mask-this-reality/

Reply on Twitter 1343561730203525122Retweet on Twitter 13435617302035251229Like on Twitter 13435617302035251227Twitter 1343561730203525122
Retweet on TwitterHealthNewsReview.org Retweeted
IJNetIJNet@IJNet·

“The distinction between what we do know and what we do not yet understand should be explained more often and more clearly in our coverage,” said @garyschwitzer. Journalists need to get past press releases from drug companies, but also debunk conspiracies. https://buff.ly/2LX9MVo

Reply on Twitter 1342696898508029952Retweet on Twitter 13426968985080299525Like on Twitter 13426968985080299529Twitter 1342696898508029952
View More

Categories

View More

Tags